Cutera Inc - CUTR STOCK NEWS

Cutera, Inc. (NASDAQ: CUTR) announced a private placement of $125 million in 2.25% convertible senior notes due 2026. The notes will not bear regular interest and have an initial conversion rate equivalent to $33.18 per share. The offering is expected to close on March 9, 2021, with net proceeds estimated at $120.7 million, intended for general corporate purposes and capped call transactions. The company may redeem the notes after March 2024 if certain stock price conditions are met. The offering is aimed at enhancing liquidity and potentially funding strategic acquisitions.

Cutera, Inc. (NASDAQ: CUTR) announced its intention to offer $125 million in convertible senior notes due 2026 in a private placement to qualified institutional buyers, with an option for initial purchasers to acquire an additional $25 million. The notes will be unsecured and convertible into cash, common stock, or a combination of both. Proceeds will fund capped call transactions and general corporate purposes, including potential acquisitions. Cutera will implement capped call transactions to reduce potential dilution of its stock upon conversion of the notes.

Cutera (NASDAQ: CUTR) reported Q4 2020 revenue of $49.9 million, down 4% year-over-year, but up 28% sequentially. Capital Equipment revenue fell 26% to $30.1 million, while Recurring Revenue surged 80% to $19.8 million, bolstered by a 363% increase in Skincare revenue. Gross Margin improved to 56.2%, and the company posted a net income of $2.2 million, a recovery from a loss last year. Full-year revenue stood at $147.7 million, down from $181.7 million in 2019. Cutera will not provide formal guidance for 2021 due to COVID-19 uncertainties.

Cutera, Inc. (Nasdaq: CUTR) will report its financial results for Q4 and the full year 2020 on February 17, 2021, after market close. Management will host a conference call at 1:30 p.m. PT (4:30 p.m. ET) to discuss the results. CEO Dave Mowry, CFO Rohan Seth, and President Jason Richey will participate in the call. Investors can join the call by dialing 1-877-705-6003 or +1-201-493-6725, using Conference Code: 13715746. The call will also be webcast on Cutera's website, with replay available shortly after the call.

Cutera, Inc. (NASDAQ: CUTR), a key player in energy-based aesthetic systems, announced that CEO Dave Mowry will speak at the Piper Sandler 32nd Annual Virtual Healthcare Conference. The pre-recorded chat will be available to registered attendees from November 24 to December 3. Additionally, it can be accessed through the 'Investors' section of the company's website for replay. Founded in 1998, Cutera specializes in developing innovative aesthetic products for safe and effective treatments.

Cutera, Inc. (NASDAQ: CUTR) is set to participate in two virtual fireside chats at investor conferences this November. The Stifel Virtual Healthcare Conference will be on November 17, 2020, at 3:20 p.m. ET, and the Stephens Virtual Investment Conference will follow on November 19, 2020, at 3:00 p.m. ET. Both discussions will feature CEO Dave Mowry. Live webcasts will be available via the Company’s website and can be replayed post-event.

Cutera, Inc. (NASDAQ: CUTR) reported third quarter 2020 revenue of $39.1 million, a 15% decline compared to last year due to COVID-19 disruptions. Capital Equipment revenue fell 31% to $24.1 million, although recurring revenue grew significantly by 35%, driven by a 140% increase in Skin Care revenue. Gross Margin was 56%, down from 57% year-over-year. Operating expenses decreased by 20% to $23.0 million, leading to a reduced net loss of $2.3 million ($0.13 per share). CEO Dave Mowry expressed optimism for future growth despite ongoing challenges from the pandemic.

NEA Medical Aesthetic Clinic in Calgary has launched truSculpt® flex, a revolutionary muscle sculpting platform from Cutera. This treatment is Health Canada cleared for strengthening and toning various muscle groups, including abs and thighs. Featuring proprietary Multi-Directional Stimulation (MDS) technology, truSculpt flex can simultaneously treat up to eight areas, making it unique in the body sculpting industry. This platform not only aids aesthetics but also addresses medical conditions like muscle wasting from injuries or surgeries, demonstrating its versatility in enhancing physical activity and health.

Cutera, Inc. (CUTR) will report its third quarter 2020 financial results after market close on November 4, 2020. A conference call is scheduled for the same day at 1:30 p.m. PT, featuring key executives including CEO Dave Mowry and CFO Rohan Seth. Investors can participate by calling 1-877-705-6003 domestically or +1-201-493-6725 internationally, using the Conference Code: 13711852. The call will also be accessible via webcast on Cutera's Investor Relations website.